Thursday, 29 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Management Change

Kimia Biosciences Management Change

Kimia Biosciences Limited announced the re-appointment of Mr. Sameer Goel as Executive Director and changes in designation for three other directors on the board.

Source

BSE filing, NSE: LAURLOR. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kimia Biosciences Ltd: key numbers

Share price
₹30.25
Market cap
₹143.1 Cr
Revenue (annual)
₹114.9 Cr
Net profit (annual)
₹7.43 Cr
P/E (TTM)
19.9×Sector 46.1×
Promoter holding
74.94%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kimia Biosciences Ltd

All →

Other management change announcements

All →